AdvertisementBlockbuster drug Humira finally faces lower-cost rivalsPlay03:51Download AudioJuly 20, 2023Sydney LupkinfacebookEmailAbbVie's Humira was the world's best-selling drug for many years. Now it faces competition for copycats that cost a fraction of its price. (AP)
